
Aurora Cannabis ACB
€ 3.15
5.17%
Geschäftsbericht 2025
hinzugefügt 21.02.2026
Aurora Cannabis Current Ratio 2011-2026 | ACB
Current Ratio Jährlich Aurora Cannabis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.49 | 3.64 | 2.29 | 2.57 | 4.59 | 4.23 | 4.95 | 2.92 | 8.25 | 0.656 | 0.143 | 3.53 | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.25 | 0.143 | 3.44 |
Current Ratio Vierteljährlich Aurora Cannabis
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 4.59 | - | - | - | 4.23 | - | - | - | 4.95 | - | - | - | 5.66 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.66 | 4.23 | 4.86 |
Current Ratio anderer Aktien in der Arzneimittelhersteller
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aerie Pharmaceuticals
AERI
|
0.961 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
2.13 | $ 1.11 | 4.25 % | $ 119 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
1.78 | - | 7.5 % | $ 6.35 M | ||
|
Catalent
CTLT
|
1.59 | - | - | $ 11.5 B | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
0.944 | - | 0.86 % | $ 117 M | ||
|
DURECT Corporation
DRRX
|
1.95 | - | - | $ 50.1 M | ||
|
Endo International plc
ENDP
|
1.77 | - | - | $ 28.9 M | ||
|
Agile Therapeutics
AGRX
|
0.386 | - | 10.11 % | $ 58.2 M | ||
|
Evoke Pharma
EVOK
|
0.733 | - | - | $ 36.6 M | ||
|
Evolus
EOLS
|
0.907 | $ 5.25 | 27.12 % | $ 338 M | ||
|
Alimera Sciences
ALIM
|
1.43 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
6.63 | $ 2.66 | 2.43 % | $ 1.38 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
1.82 | - | - | $ 2.06 B | ||
|
Harrow Health
HROW
|
1.15 | $ 39.73 | 2.91 % | $ 1.46 B | ||
|
Jupiter Wellness
JUPW
|
0.772 | - | - | $ 33.6 M | ||
|
China Pharma Holdings
CPHI
|
2.09 | $ 0.58 | 4.69 % | $ 10.1 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
1.43 | $ 4.21 | -8.08 % | $ 59.2 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
9.82 | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
1.85 | - | 2.45 % | $ 38.1 M | ||
|
Neoleukin Therapeutics
NLTX
|
6.09 | - | - | $ 193 M | ||
|
Athenex
ATNX
|
0.894 | - | -23.39 % | $ 1.76 M | ||
|
Organogenesis Holdings
ORGO
|
4.42 | $ 2.96 | 3.14 % | $ 390 M | ||
|
Emergent BioSolutions
EBS
|
1.55 | $ 8.72 | -2.24 % | $ 446 M | ||
|
ProPhase Labs
PRPH
|
3.65 | - | - | $ 5.07 M | ||
|
Assertio Holdings
ASRT
|
1.93 | $ 12.24 | 2.9 % | $ 869 M | ||
|
Radius Health
RDUS
|
0.418 | - | - | $ 1.42 B | ||
|
Rockwell Medical
RMTI
|
1.69 | $ 0.9 | 0.13 % | $ 21 M | ||
|
Bausch Health Companies
BHC
|
0.997 | $ 5.62 | -2.01 % | $ 2.05 B | ||
|
Lannett Company
LCI
|
0.659 | - | 1.15 % | $ 7.11 M | ||
|
Eagle Pharmaceuticals
EGRX
|
2.35 | - | -39.89 % | $ 27.7 M | ||
|
OrganiGram Holdings
OGI
|
4 | $ 1.4 | 2.12 % | $ 402 M | ||
|
Perrigo Company plc
PRGO
|
1.52 | $ 11.55 | 1.45 % | $ 1.6 B | ||
|
Sundial Growers
SNDL
|
6.25 | $ 1.56 | 1.63 % | $ 3.37 M | ||
|
TherapeuticsMD
TXMD
|
3.09 | $ 2.24 | 0.94 % | $ 23.4 M | ||
|
Pacira BioSciences
PCRX
|
2 | $ 22.72 | 2.81 % | $ 1.05 B | ||
|
PetIQ
PETQ
|
2.4 | - | 1.64 % | $ 400 M | ||
|
OptiNose
OPTN
|
0.554 | - | - | $ 1.08 B | ||
|
Veru
VERU
|
2.15 | $ 2.66 | 5.56 % | $ 359 M | ||
|
Viatris
VTRS
|
1.73 | $ 14.7 | -1.31 % | $ 17.6 B | ||
|
PLx Pharma
PLXP
|
3.07 | - | -27.8 % | $ 2.56 M | ||
|
Recro Pharma
REPH
|
1.62 | - | -4.76 % | $ 65.3 M | ||
|
Relmada Therapeutics
RLMD
|
8 | $ 4.78 | 2.36 % | $ 144 M | ||
|
cbdMD
YCBD
|
1.23 | $ 0.8 | 2.62 % | $ 3.45 M | ||
|
SCYNEXIS
SCYX
|
2.32 | $ 0.77 | 2.05 % | $ 36.8 M | ||
|
Solid Biosciences
SLDB
|
3.67 | $ 6.17 | 3.52 % | $ 252 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
1.48 | $ 2.72 | -1.09 % | $ 3.38 M | ||
|
Tricida
TCDA
|
1 | - | - | $ 3.25 M | ||
|
Tilray
TLRY
|
4.41 | $ 7.52 | 2.17 % | $ 4.65 B | ||
|
Zynerba Pharmaceuticals
ZYNE
|
5.98 | - | - | $ 55.5 M |